-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pasithea Therapeutics Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2024.
- Pasithea Therapeutics Corp. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.26M, a 36.7% increase year-over-year.
- Pasithea Therapeutics Corp. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$14.2M, a 10.8% increase year-over-year.
- Pasithea Therapeutics Corp. annual Operating Income (Loss) for 2024 was -$14.2M, a 10.8% increase from 2023.
- Pasithea Therapeutics Corp. annual Operating Income (Loss) for 2023 was -$16M, a 26.9% decline from 2022.
- Pasithea Therapeutics Corp. annual Operating Income (Loss) for 2022 was -$12.6M, a 179% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)